Oncology Institute drops as CEO steps down
** Shares of cancer care provider Oncology Institute Inc
TOI.O falls ~10% to $0.55 before the bell
** Co said its CEO Brad Hively would step down at the end of
June
** Daniel Virnich, current president of co, will become CEO
** Hively will transition to the role of Vice Chairman of
Board
** TOI stock down 62.42% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Oncology Institute
See all newsOncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions